Last Updated
Overview
Profluent provides a revolutionary generative Artificial Intelligence (AI) platform for designing novel proteins, enabling the creation of bespoke therapeutics and enzymes. While it is not a self-serve tool and requires deep collaboration, the software’s ability to create solutions for previously unsolvable biological problems offers a significant competitive advantage for partners.
Be the first one to leave a review!
No review found
Starting Price
Custom
Profluent Specifications
Predictive Capabilities
Automation
Entity Extraction With Text Analytics
Natural Language Dialogue
What Is Profluent?
Profluent is a pioneering artificial intelligence company that moves beyond discovery to intentionally design and author new biology. Its platform uses advanced generative AI models, trained on vast biological datasets, to write entirely new, functional proteins from scratch. By enabling the simultaneous optimization of multiple attributes and offering access to unparalleled sequence diversity, Profluent empowers partners in therapeutics and agriculture to create solutions once thought impossible. This innovation accelerates both research and commercial success.
Profluent Pricing
The Profluent price for bespoke protein design is determined through custom agreements tailored to the specific project's scope and goals.
Profluent Integrations
Who Is Profluent For?
Profluent is ideal for a wide range of users across medical laboratories, including:
- Therapeutics
- Gene editing
- Agriculture
- Industrial enzyme development
- Pharmaceuticals
Is Profluent Right For You?
If your organization is confronting fundamental Research and Development (R&D) roadblocks that existing biological tools cannot overcome, Profluent may be the right partner for you. The platform is not an off-the-shelf tool but a gateway to a deep, collaborative partnership aimed at solving intractable problems. Its standout success in creating OpenCRISPR, the world's first AI-designed gene editor, demonstrates its profound capabilities. This achievement, recognized by its inclusion in Fortune's ‘50 AI Innovators’ list, positions Profluent as an essential collaborator for any company seeking to lead the next wave of biological innovation.
Are you still not sure about Profluent and need expert advice to make an informed decision? Reach out to us at (661) 384-7070 now.
Profluent Features
The platform’s core capability allows it to author entirely new proteins from scratch rather than modifying existing ones. This AI-first approach enables the creation of molecules with precisely tailored functions to meet specific therapeutic or industrial needs.
Profluent’s AI can simultaneously optimize a protein for multiple complex attributes, such as stability, activity, and specificity. This holistic process streamlines development, making it more feasible for partners to achieve commercially viable and effective biological solutions.
The platform has proven its ability to generate highly functional, novel genome editors, exemplified by OpenCRISPR. This feature allows for the rapid design and customization of gene editing systems for specific therapeutic applications and research purposes.
By using AI to extrapolate into new protein spaces, the platform can generate designs with immense diversity, going far beyond sequences found in nature or existing patents. This unlocks unique possibilities for intellectual property and functional advantages.
